Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Medicago Inc MDCGF



GREY:MDCGF - Post by User

Comment by rocket65on Jan 25, 2011 5:13pm
212 Views
Post# 18025149

RE: big pharma will be looking for game changers i

RE: big pharma will be looking for game changers iFrom what I remember, Phillip Morris owns... correct me if I'm wrong, but something like %46 of this company? So the company officers, scientific advisers and fellow longs will account for another couple of percents. So if there's a buyout option and it goes to shareholder vote.... AND Phillip Morris doesn't want to play, then it will be a  tough company to buy. Phillip Morris isn't desperate for more money. Steady cash is usually better than a one time wallop.

Buyouts for companies like this is usually done by boys in the back room with friends. The new guy on the block for Medicago is Mr. Kirkconnell, who used to be a fairly significant heavyweight at Aventis. Whom you will be advised has a fairly healthy vaccine business. It's these kind of connections that will get you far. MDG has lots of talent in the boardroom with lots of big pharma connections. But buyout isn't necessarily the best thing.  Steady huge income from really impressive vaccine patents can turn all sorts of investors on, let alone small -> large cap fund managers.

Forcast: T minus 8 days until trial result are posted. So results will be posted on Monday Jan 31, or Feb 1.

Day traders will pound the crap out of this stock to bring it down from a high of $1.75 to .90 as there aren't enough buyers and knowledge of this company. As more trial result confirmations are brought forward, more press etc... price will go back up to $1.50 until such time as the next business decision comes in.

All forward looking statements, and pure speculation. But it is fun.

Go longs.

<< Previous
Bullboard Posts
Next >>